Long-Term Response to Galantamine in Relation to Short-Term Efficacy Data: Pooled Analysis in Patients with Mild to Moderate Alzheimer’s Disease

BACKGROUND: This analysis aimed to identify an operational, clinically relevant definition of response achieved in short-term clinical trials to support the identification of patients with Alzheimer’s disease (AD) who would benefit most from long-term galantamine therapy. METHODS: Data were analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavanagh, S, Howe, I, Brashear, H R, Wang, D, Baelen, B Van, Todd, M, Schwalen, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers Ltd 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182415/
https://www.ncbi.nlm.nih.gov/pubmed/21222607
http://dx.doi.org/10.2174/156720511795256044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182415/
https://www.ncbi.nlm.nih.gov/pubmed/21222607
http://dx.doi.org/10.2174/156720511795256044

Ejemplares similares